RxDoctor Payments Data

Jennifer Cooper, MD

MOHS-Micrographic Surgery · Abingdon, MDNPI 1619918356

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,329, 6.8 times the $194 reported in 2019.

$2,709in general payments, 2019–2025

Across 101 payments — averaging $26.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$609
  • Sanofi$322
  • Regeneron Healthcare Solutions, Inc.$239
  • Novartis$224
  • Lilly USA, LLC$189
  • Revance Therapeutics, Inc.$188
  • plus $937 from 21 others

What the payments were for

  • Food & beverage$2,68799%
  • Education$221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,709 in reported general payments places this provider in the 65th percentile of 26 mohs-micrographic surgery providers in Maryland.

See all mohs-micrographic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$876,654
Medicare patients
1,088
Services billed
4,960

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate76$4,276
Gentamicin Sulfate105$3,341
Acitretin11$2,512
Fluorouracil35$2,279
Betamethasone Valerate19$1,105
Metronidazole26$985
Doxycycline Hyclate30$980
Ketoconazole35$972
Triamcinolone Acetonide98$694
Imiquimod16$567
Mupirocin55$361
Cephalexin27$84
ValacyclovirValacyclovir Hcl14$68

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Abingdon

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →